Additionally, we evaluated the effectiveness of PPC on the liver fibrosis risk indicator FIB-4, biochemical indices of liver function (ALT, AST, total bilirubin), and blood lipid (LDL-C) levels. The gene discussed is GPT; the disease is Hepatic fibrosis.